Association of White Matter Hyperintensities With HIV Status and Vascular Risk Factors

Yair Mina1, Tianxia Wu1, Hsing-Chuan Hsieh1

  • 1From the National Institute of Neurological Disorders and Stroke (Y.M., T.W., E.H., D.S.R., A.N., B.R.S.), Center for Infectious Disease Imaging, Radiology and Imaging Sciences, Clinical Center (D.A.H., S.S.), National Institute of Allergy and Infectious Diseases (C.-Y.L., E.C.T.), National Institute of Mental Health (L.H., J.S.), and National Institute on Alcohol Abuse and Alcoholism (S.I.R.), National Institutes of Health, Bethesda, MD; Sackler Faculty of Medicine (Y.M.), Tel Aviv University, Israel; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics (H.-C.H., A.G., B.K.A.), Uniformed Services University of the Health Sciences; and Henry M. Jackson Foundation for the Advancement of Military Medicine Inc. (H.-C.H., A.G., B.K.A.), Bethesda, MD.

Neurology
|February 27, 2021
PubMed
Summary

People living with HIV (PLWH) show significantly higher brain white matter hyperintensities (WMH) even with controlled infection. Aging and modifiable comorbidities are key factors associated with increased WMH in PLWH.